ID: ALA3596476

Max Phase: Preclinical

Molecular Formula: C26H25F4NO

Molecular Weight: 443.48

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Fc1ccc(-c2cc(COCC3(c4ccccc4)CCNCC3)cc(C(F)(F)F)c2)cc1

Standard InChI:  InChI=1S/C26H25F4NO/c27-24-8-6-20(7-9-24)21-14-19(15-23(16-21)26(28,29)30)17-32-18-25(10-12-31-13-11-25)22-4-2-1-3-5-22/h1-9,14-16,31H,10-13,17-18H2

Standard InChI Key:  JSPOESIPSSVBCT-UHFFFAOYSA-N

Associated Targets(non-human)

Substance-P receptor 55 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 443.48Molecular Weight (Monoisotopic): 443.1872AlogP: 6.35#Rotatable Bonds: 6
Polar Surface Area: 21.26Molecular Species: BASEHBA: 2HBD: 1
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 10.03CX LogP: 6.13CX LogD: 3.60
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.45Np Likeness Score: -0.49

References

1. Degnan AP, Tora GO, Han Y, Rajamani R, Bertekap R, Krause R, Davis CD, Hu J, Morgan D, Taylor SJ, Krause K, Li YW, Mattson G, Cunningham MA, Taber MT, Lodge NJ, Bronson JJ, Gillman KW, Macor JE..  (2015)  Biaryls as potent, tunable dual neurokinin 1 receptor antagonists and serotonin transporter inhibitors.,  25  (15): [PMID:26048800] [10.1016/j.bmcl.2015.04.098]

Source